Qualigen Therapeutics
QLGN
QLGN
26 hedge funds and large institutions have $1.85M invested in Qualigen Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
26
Holding in Top 10
–
Calls
$58K
Puts
–
Top Buyers
| 1 | +$82K | |
| 2 | +$75K | |
| 3 | +$29K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$23K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$18K |
Top Sellers
| 1 | -$107K | |
| 2 | -$87K | |
| 3 | -$52K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$8K |